These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6144632)

  • 21. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril).
    Fouad FM; Tarazi RC; Bravo EL; Textor SC
    Hypertension; 1984; 6(2 Pt 1):167-74. PubMed ID: 6327515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol.
    Franciosa JA; Freis ED; Conway J
    Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P; Omvik P
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol.
    Lund-Johansen P; Ohm OJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():481S-483S. PubMed ID: 15759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system.
    Schmidt BM; Georgens AC; Martin N; Tillmann HC; Feuring M; Christ M; Wehling M
    J Clin Endocrinol Metab; 2001 Feb; 86(2):761-7. PubMed ID: 11158043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic and physiologic considerations of adrenoceptor blockade.
    Frohlich ED; Dunn FG; Messerli FH
    Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of systemic autonomic inhibition on the hemodynamic response to antihypertensive therapy with timolol.
    Simon G; Kiowski W; Julius S
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):507-10. PubMed ID: 528098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
    Levenson J; Simon A; Temmar M; Safar M
    Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T; Komeichi H; Nagano T; Ohsuga M; Terada H; Katsuta Y; Satomura K; Aramaki T
    Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of beta-blockade hypotension.
    Frohlich ED
    N Engl J Med; 1972 Dec; 287(24):1247-8. PubMed ID: 4404400
    [No Abstract]   [Full Text] [Related]  

  • 32. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influences of dihydralazine and dynamic exercise and clinical effects of combined treatment.
    Sannerstedt R; Stenberg J; Vedin A; Wilhelmsson C; Werkö L
    Am J Cardiol; 1972 May; 29(5):718-23. PubMed ID: 4401785
    [No Abstract]   [Full Text] [Related]  

  • 34. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the contributions of autoregulatory mechanisms to the antihypertensive actions of beta-adrenergic therapy.
    Cowley AW
    Hypertension; 1984; 6(2 Pt 1):137-9. PubMed ID: 6144630
    [No Abstract]   [Full Text] [Related]  

  • 37. Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine.
    Kiowski W; Bertel O; Erne P; Bolli P; Hulthén UL; Ritz R; Bühler FR
    Hypertension; 1983; 5(2 Pt 2):I70-4. PubMed ID: 6337962
    [No Abstract]   [Full Text] [Related]  

  • 38. The hemodynamic effects of adrenergic blocking agents.
    Lund-Johansen P
    Cleve Clin J Med; 1992; 59(2):193-200. PubMed ID: 1350235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.
    Atterhög JH; Dunér H; Pernow B
    Acta Med Scand; 1976; 199(4):251-5. PubMed ID: 1266662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effect of atenolol on hemodynamic, plasma renin activity and plasma aldosterone concentration in the once daily oral administration.
    Sasaki Y; Arakawa K
    Jpn Circ J; 1984 Sep; 48(9):988-93. PubMed ID: 6384568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.